The Latest

Dolutegravir Preconception Signal: Time Is Up for Shoddy Surveillance

"It is hard to imagine how in 2018 we could be in this situation where women with HIV are being so woefully underserved," Polly Clayden writes.

By Polly Clayden for HIV i-Base

U=U Offers a 'Message of Hope' for People Living With HIV -- and Providers Need to Spread the Word

Leading researchers and clinicians who influence best practices for conversations about the direct and indirect impact of HIV infection and treatment agree that communications regarding transmission must shift.

By Ace Robinson

Today Is the Day: A Call to Action for Providers During LGBTQ Pride Month

"The LGBTQ community needs health care providers to open their eyes and commit to our health, well-being, and healing," Jessica Halem writes. "We need them to be aware of our history and the reasons why so many of us don't trust that doctors and nurs...

By Jessica Halem, M.B.A.

Strategies for a Cure

Three researchers talk about ongoing HIV cure research within the AIDS Clinical Trials Group, treatment interruptions, and when we might see a cure.

By Karine Dubé and Jeff Berry for Positively Aware

State-Level PrEP Utilization Data Now Available From AIDSVu

The new maps from AIDSVu show more than 77,000 people were prescribed PrEP in 2016, with an average 73 percent increase year over year in persons using PrEP across the U.S. from 2012.


The Usual Suspects: Common Challenges for End the Epidemic Planning and Implementation in Emerging Jurisdictions

Leaders and experts in End the Epidemic planning processes share their perspectives on some of the most common roadblocks.

By Jeremiah Johnson for Treatment Action Group

U=U: What HIV Providers Should Know

Due to community pressure and activism, the language that physicians, scientists, and public health bodies use to describe the potential for HIV transmission when a person has an undetectable viral load is now much clearer.

By Roger Pebody

More Women Must Be Included in Academia and in Clinical Trials, Panelists Demand

Presentations on women in research at this year's Conference on Retroviruses and Opportunistic Infections highlighted the lack of inclusion, offered ideas on how to remedy the situation, and showed how one woman moved from advocate to researcher.

By Barbara Jungwirth

More HIV Research Highlights From CROI 2018

Three video interviews with federal HIV leaders who shared perspectives about the science coming out of the conference and its implications for HIV prevention, care, and treatment.


The Cost of Cuts in HIV Spending: A Top HIV Clinical Development of 2017

2017 could have been worse. Although propelled to power by blustery threats to cut or eliminate publicly funded programs, including those that keep people living with HIV alive and well, the new administration has largely been unable to convert rheto...

By David Alain Wohl, M.D.